Patient Preferences Regarding Side Effects of Chemotherapy for Ovarian Cancer: Do They Change over Time?-Reference-Cited by-同舟云学术

Patient Preferences Regarding Side Effects of Chemotherapy for Ovarian Cancer: Do They Change over Time?

Published:2002-10 Issue:1 Volume:87 Page:118-128
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Sun Charlotte C.,Bodurka Diane C.,Donato Michele L.,Rubenstein Edward B.,Borden Candice L.,Basen-Engquist Karen,Munsell Mark F.,Kavanagh John J.,Gershenson David M.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference22 articles.

1. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results;Bertucci;Bone Marrow Transplant,2000

2. Patient preference for cancer therapy: an overview of measurement approaches;Stiggelbout;J Clin Oncol,2001

3. Utilities and quality-adjusted life years;Torrance;Intl J Technol Assess Health Care,1989

4. Methods for the economic evaluation of health care programmes;Drummond,1997

5. Guide to design and development of health-state utility instrumentation;Furlong,1990

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determination of quality of life-related health utilities for surgical complications in ovarian cancer;Gynecologic Oncology;2024-06

2. Assessment of the change of antiemetic prophylaxis from double to triple combination in patients with high dose carboplatin chemotherapy;Journal of Oncology Pharmacy Practice;2023-08-10

3. Nanocargos designed with synthetic and natural polymers for ovarian cancer management;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-07-08

4. Palliative care and quality of life;DiSaia and Creasman Clinical Gynecologic Oncology;2023

5. Assessment of the Change of Antiemetic Prophylaxis From a Double Combination to a Triple Combination in Oncology Patients With High Dose Carboplatin Chemotherapy;2022-12-15